Home | ClinicalTrials.gov
ClinicalTrials.gov is a website and online database of clinical research studies and information about their results
Jun 27, 2018 · The final rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11) specifies requirements for submitting clinical trial information to ClinicalTrials.gov.
ClinicalTrials.gov PRS: Login
Welcome to the ClinicalTrials.gov Protocol Registration and Results System (PRS).
To evaluate the clinical response in Cw6-negative and Cw6-positive patients treated with secukinumab 300 mg with respect to the Psoriasis Area Severity Index (PASI) 90 response rate after 16 weeks, …
Statistical Analysis Plan
A RANDOMIZED, DOUBLE-BLIND, SINGLE-DOSE, THREE-ARM, PARALLEL-GROUP, PHASE 1 STUDY TO COMPARE PHARMACOKINETIC AND SAFETY OF TRS003 TO CHINA-APPROVED …
The risk to patients in this trial will be minimized by compliance with the eligibility criteria, close clinical monitoring and extensive guidance to the investigators, provided in the current version of the IB.
Study medication continued as long as patient was obtaining clinical benefit, or until significant toxicity, or withdrawal of consent, for up to 24 months. INX123 75.0 mg once daily on a continuous daily …
Information will be provided volunteers about the clinical study and a consent shall be obtained prior to screening commencement. Participants will be screened for health conditions, their medical history …
Overview: The Baseline Characteristics module is a tabular summary of data for each demographic and base-line measure by arm or comparison group and for the entire population of participants in the …
Participant Flow Data Preparation Checklist Overview: The Participant Flow module is a tabular summary of participants’ progress through each stage of a study by assignment group. Use this …